Dr. Siddhartha Ganguly
Claim this profileHouston Methodist Hospital
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
5 reported clinical trials
9 drugs studied
Area of expertise
1Multiple Myeloma
Stage III
Stage IV
2Plasma Cell Neoplasms
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Siddhartha Ganguly is currently running
Ide-cel + Lenalidomide
for Multiple Myeloma
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
Recruiting2 awards Phase 31 criteria
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting2 awards Phase 312 criteria
More about Siddhartha Ganguly
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Siddhartha Ganguly has experience with
- Lenalidomide
- Idecabtagene Vicleucel
- Fludarabine
- Cyclophosphamide
- Rituximab
- Autologous Hematopoietic Stem Cell Transplantation
Breakdown of trials Siddhartha Ganguly has run
Multiple Myeloma
Plasma Cell Neoplasms
Mantle Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Siddhartha Ganguly specialize in?
Siddhartha Ganguly focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved Stage III patients, or patients who are Stage IV.
Is Siddhartha Ganguly currently recruiting for clinical trials?
Yes, Siddhartha Ganguly is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Siddhartha Ganguly has studied deeply?
Yes, Siddhartha Ganguly has studied treatments such as Lenalidomide, Idecabtagene Vicleucel, Fludarabine.
What is the best way to schedule an appointment with Siddhartha Ganguly?
Apply for one of the trials that Siddhartha Ganguly is conducting.
What is the office address of Siddhartha Ganguly?
The office of Siddhartha Ganguly is located at: Houston Methodist Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.